The genome editing market in Europe is expected to grow from US$ 1,487.30 million in 2021 to US$ 4,791.46 million by 2028; it is estimated to grow at a CAGR of 18.2% from 2021 to 2028.
Over the past few years, advances in genome editing technologies have been making constant headlines. Genome editing technologies can alter biological research and significantly impact human health, food security, and environmental sustainability since they are precise, relatively inexpensive, easy to use, and remarkably powerful. The advances in genome editing can be traced back to quiet beginnings in the 1990s. The introduction of CRISPR-Cas9—a genome-editing tool that can be used to make precise and targeted changes in the DNA sequence with ease—is mainly responsible for the recent rise in the amount and scope of applications of genome editing technologies. The CRISPR platform's ease of use, as compared to previous technologies, has resulted in its widespread adoption and application. Genome editing could have a favorable impact on sustainable development, environmental management, food security, and the introduction of affordable diagnostics and therapies for various diseases due to these advancements. Recognizing the potential of genome editing techniques for studying and manipulating the genome, the DBT has been fostering research and innovation in genome engineering technologies and applications to make them more accessible and inexpensive for research and development (R & R&D). Through focused calls for proposals in different areas such as the development of new methods, tools, processes, and platforms for genome editing, improvement of existing genome-editing methods, and novel applications of genome editing technologies in agriculture, bioenergy, environmental research, and human health, efforts have been made to encourage R&D programs in emerging genome engineering technologies and their applications. Despite contributing to one-third of all deaths worldwide, there is no effective treatment, to date, for fibrosis. This study has established PAI-1 as a novel drug target, and pharmacologically targeting this protein may be an effective treatment for combating fibrosis. These factors for CRISPR system research are likely to favor the market's growth.
Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. The cell therapy instruments supply chain, which is already logistically complicated, has to face new challenges. The cell therapy instrument market has also witness some shortfall at the beginning of COVID 19 crisis owing to factors such as disruption in supply chain and demand due to lock down announced by majority of European countries. For instance, in July 2020 the UK government has allotted 100 million Euros funds to the Cell and Gene Therapy Catapult Manufacturing Innovation Centre to expedite the production of a vaccine for COVID-19 in the UK. Moreover, Stempeutics Research has filed application seeking European Commission Funding to develop cell therapy for COVID 19. The company has also entered into partnership with global consortium of cell therapy companies to gather funding for cell therapy research from European commission. Hence, Europe market is likely to show significant growth prospects during this pandemic and forecasted year.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe genome editing market. The Europe genome editing market is expected to grow at a good CAGR during the forecast period.
Europe Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Europe Genome Editing Market Segmentation
Europe Genome Editing Market – By Technology
- CRISPR
- TALEN
- Antisense
- Other
Europe Genome Editing Market – By Application
- Cell Line Engineering
- Genetic Engineering
- Diagnostic Applications
- Drug Discovery
- Others
Europe Genome Editing Market – By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Clinical Research Organizations (CRO's)
Europe Genome Editing Market – By Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Europe Genome Editing Market – Companies Mentioned
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA
- Lonza
- Horizon Discovery Group plc.
- Integrated DNA Technologies
- GenScript
- New England Biolabs
- Eurofins Scientific
- CRISPR Therapeutics
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Genome Editing Market– By Technology
1.3.2 Europe Genome Editing Market– By Application
1.3.3 Europe Genome Editing Market– By End User
1.3.4 Europe Genome Editing Market– By Country
2. Europe Genome Editing Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Genome Editing Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. Europe Genome EditingMarket – Key Market Dynamics
5.1 Market Drivers
5.1.1 Burgeoning Prevalence of Cancer and Other Genetic Disorders
5.1.2 Progressive Technological Advancements in Gene-Editing Tools
5.2 Market Restraints
5.2.1 Expensive Cost of Genomic Equipment
5.3 Future Trends
5.3.1 Growing Technological Innovations
5.4 Impact Analysis
6. Europe Genome Editing Market Analysis
6.1 Europe Genome Editing Market Revenue Forecast and Analysis
7. Europe Genome Editing Market Revenue and Forecasts to 2028– by Technology
7.1 Overview
7.2 Europe Genome Editing Market, By Technology, 2021 & 2028 (%)
7.3 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
7.3.1 Overview
7.3.2 CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.4 TALEN
7.4.1 Overview
7.4.2 TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.5 Antisense
7.5.1 Overview
7.5.2 Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8. Europe Genome Editing Market Revenue and Forecasts to 2028 – Application
8.1 Overview
8.2 Europe Genome Editing Market Share, By Application - 2021 & 2028 (%)
8.3 Cell Line Engineering
8.3.1 Overview
8.3.2 Cell Line Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Genetic Engineering
8.4.1 Overview
8.4.2 Genetic Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.5 Diagnostic Applications
8.5.1 Overview
8.5.2 Diagnostic Applications: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Discovery
8.6.1 Overview
8.6.2 Drug Discovery: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9. Europe Genome Editing Market Revenue and Forecasts to 2028 – End User
9.1 Overview
9.2 Europe Genome Editing Market Share by End User - 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinical Research Organizations (CRO’s)
9.4.1 Overview
9.4.2 Clinical Research Organizations: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10. Europe Genome Editing Market – Country Analysis
10.1 Overview
10.1.1 Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4 Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5 Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4 France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5 France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5 UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4 Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5 Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.4 Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5 Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.4 Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5 Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Europe Genome Editing Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Europe Genome Editing Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lonza
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Integrated DNA Technologies
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 GenScript
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 New England Biolabs
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eurofins Scientific
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CRISPR Therapeutics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 4. France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 5. France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 6. France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 9. UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms, Europe Genome Editing Market
LIST OF FIGURES
Figure 1. Europe Genome Editing Market Segmentation
Figure 2. Europe Genome Editing Market Segmentation, By Country
Figure 3. Europe Genome Editing Market Overview
Figure 4. CRISPR Held Largest Share of Technology Segment in Europe Genome Editing Market
Figure 5. Germany to Show Remarkable Growth During Forecast Period
Figure 6. Europe Genome Editing Market, Industry Landscape
Figure 7. Europe: PEST Analysis
Figure 8. Expert Opinion
Figure 9. Europe Genome Editing Market Impact Analysis of Drivers and Restraints
Figure 10. Europe Genome Editing Market– Revenue Forecast and Analysis – 2021-2028
Figure 11. Europe Genome Editing Market, by Technology, 2021 & 2028 (%)
Figure 12. CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Genome Editing Market Share, by Application - 2021 & 2028 (%)
Figure 17. Cell Line Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Genetic Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Diagnostic Applications: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Drug Discovery: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Others: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Europe Genome Editing Market Share by End User - 2021 & 2028 (%)
Figure 23. Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Clinical Research Organizations: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Academic and Research Institutes: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Europe: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)
Figure 27. Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 28. Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Impact of COVID-19 Pandemic in European Country Markets
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA
- Lonza
- Horizon Discovery Group plc.
- Integrated DNA Technologies
- GenScript
- New England Biolabs
- Eurofins Scientific
- CRISPR Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Genome Editing Market
Mar 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Mar 2022